ID

37010

Description

Effectiveness of Rebif® in Clinically Isolated Syndrome and Relapsing Multiple Sclerosis Using RebiSmart™ (PROCEED); ODM derived from: https://clinicaltrials.gov/show/NCT02254304

Link

https://clinicaltrials.gov/show/NCT02254304

Keywords

  1. 6/29/19 6/29/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

June 29, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Relapsing Multiple Sclerosis NCT02254304

Eligibility Relapsing Multiple Sclerosis NCT02254304

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male and female subjects between 18 to 65 years of age
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
female subjects must be neither pregnant nor breast-feeding and must lack child-bearing potential as defined in the protocol
Description

Gender | Pregnancy Absent | Breast Feeding Absent | Childbearing Potential Lacking

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0032961
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0006147
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C3831118
UMLS CUI [4,2]
C0332268
subjects diagnosed with cis or rms according to the revised mcdonald criteria (2010)
Description

Clinically isolated syndrome | Multiple sclerosis relapse

Data type

boolean

Alias
UMLS CUI [1]
C2921627
UMLS CUI [2]
C0856120
treatment-naive subjects or subjects treated with rebif® multi-dose injected by rebismart™ for no longer than 6 weeks prior to baseline visit
Description

Therapy naive | Rebif Injectable Product Dose multiple | Other Coding

Data type

boolean

Alias
UMLS CUI [1]
C0919936
UMLS CUI [2,1]
C3232239
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0439064
UMLS CUI [3]
C3846158
subjects that are able to self-inject with rebismart™ (in the opinion of the physician)
Description

Injection Self Injector | Other Coding

Data type

boolean

Alias
UMLS CUI [1,1]
C1533685
UMLS CUI [1,2]
C0036588
UMLS CUI [1,3]
C0181342
UMLS CUI [2]
C3846158
subjects with expanded disability status scale (edss) score less than (<) 6 (inclusive) at baseline
Description

EDSS

Data type

boolean

Alias
UMLS CUI [1]
C0451246
signed informed consent and subject data collection form
Description

Informed Consent | Data Collection Consent Form

Data type

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2,1]
C0010995
UMLS CUI [2,2]
C0009797
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
subjects experiencing a relapse within 30 days before baseline
Description

Relapse

Data type

boolean

Alias
UMLS CUI [1]
C0035020
participation in other studies within 30 days before baseline
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
received any ms therapy within 6 months prior to study enrolment (for example, other disease-modifying drugs: immunomodulatory, immunosuppressive agents or combination therapy) with the exception of rebif® multi-dose injected by rebismart™
Description

Therapy Multiple Sclerosis | Biological Response Modifiers | Immunomodulators | Immunosuppressive Agents | Combined Modality Therapy | Exception Rebif Dose multiple

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0026769
UMLS CUI [2]
C0005525
UMLS CUI [3]
C1527392
UMLS CUI [4]
C0021081
UMLS CUI [5]
C0009429
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C3232239
UMLS CUI [6,3]
C0178602
UMLS CUI [6,4]
C0439064
any visual or physical impairment that precludes the subject from self-injecting the treatment using the rebismart™
Description

Visual Impairment Excludes Injection Self | Physical impairment Excludes Injection Self

Data type

boolean

Alias
UMLS CUI [1,1]
C3665347
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C1533685
UMLS CUI [1,4]
C0036588
UMLS CUI [2,1]
C0231171
UMLS CUI [2,2]
C0332196
UMLS CUI [2,3]
C1533685
UMLS CUI [2,4]
C0036588
pregnancy and breast-feeding
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
serious or acute heart disease such as uncontrolled cardiac dysrhythmias, uncontrolled angina pectoris, cardiomyopathy, or uncontrolled congestive heart failure, as per investigator opinion
Description

Heart Disease Serious | Heart Disease | Cardiac Arrhythmia Uncontrolled | Angina Pectoris Uncontrolled | Cardiomyopathy | Congestive heart failure Uncontrolled

Data type

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C0205404
UMLS CUI [2]
C0018799
UMLS CUI [3,1]
C0003811
UMLS CUI [3,2]
C0205318
UMLS CUI [4,1]
C0002962
UMLS CUI [4,2]
C0205318
UMLS CUI [5]
C0878544
UMLS CUI [6,1]
C0018802
UMLS CUI [6,2]
C0205318
current or past (within the last 2 years) history of alcohol or drug abuse
Description

Substance Use Disorders

Data type

boolean

Alias
UMLS CUI [1]
C0038586
have any contra-indications to treatment with interferon beta-1a according to summary of product characteristics
Description

Medical contraindication Interferon beta-1a

Data type

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0254119

Similar models

Eligibility Relapsing Multiple Sclerosis NCT02254304

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
male and female subjects between 18 to 65 years of age
boolean
C0001779 (UMLS CUI [1])
Gender | Pregnancy Absent | Breast Feeding Absent | Childbearing Potential Lacking
Item
female subjects must be neither pregnant nor breast-feeding and must lack child-bearing potential as defined in the protocol
boolean
C0079399 (UMLS CUI [1])
C0032961 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0006147 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C3831118 (UMLS CUI [4,1])
C0332268 (UMLS CUI [4,2])
Clinically isolated syndrome | Multiple sclerosis relapse
Item
subjects diagnosed with cis or rms according to the revised mcdonald criteria (2010)
boolean
C2921627 (UMLS CUI [1])
C0856120 (UMLS CUI [2])
Therapy naive | Rebif Injectable Product Dose multiple | Other Coding
Item
treatment-naive subjects or subjects treated with rebif® multi-dose injected by rebismart™ for no longer than 6 weeks prior to baseline visit
boolean
C0919936 (UMLS CUI [1])
C3232239 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0439064 (UMLS CUI [2,3])
C3846158 (UMLS CUI [3])
Injection Self Injector | Other Coding
Item
subjects that are able to self-inject with rebismart™ (in the opinion of the physician)
boolean
C1533685 (UMLS CUI [1,1])
C0036588 (UMLS CUI [1,2])
C0181342 (UMLS CUI [1,3])
C3846158 (UMLS CUI [2])
EDSS
Item
subjects with expanded disability status scale (edss) score less than (<) 6 (inclusive) at baseline
boolean
C0451246 (UMLS CUI [1])
Informed Consent | Data Collection Consent Form
Item
signed informed consent and subject data collection form
boolean
C0021430 (UMLS CUI [1])
C0010995 (UMLS CUI [2,1])
C0009797 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Relapse
Item
subjects experiencing a relapse within 30 days before baseline
boolean
C0035020 (UMLS CUI [1])
Study Subject Participation Status
Item
participation in other studies within 30 days before baseline
boolean
C2348568 (UMLS CUI [1])
Therapy Multiple Sclerosis | Biological Response Modifiers | Immunomodulators | Immunosuppressive Agents | Combined Modality Therapy | Exception Rebif Dose multiple
Item
received any ms therapy within 6 months prior to study enrolment (for example, other disease-modifying drugs: immunomodulatory, immunosuppressive agents or combination therapy) with the exception of rebif® multi-dose injected by rebismart™
boolean
C0087111 (UMLS CUI [1,1])
C0026769 (UMLS CUI [1,2])
C0005525 (UMLS CUI [2])
C1527392 (UMLS CUI [3])
C0021081 (UMLS CUI [4])
C0009429 (UMLS CUI [5])
C1705847 (UMLS CUI [6,1])
C3232239 (UMLS CUI [6,2])
C0178602 (UMLS CUI [6,3])
C0439064 (UMLS CUI [6,4])
Visual Impairment Excludes Injection Self | Physical impairment Excludes Injection Self
Item
any visual or physical impairment that precludes the subject from self-injecting the treatment using the rebismart™
boolean
C3665347 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C1533685 (UMLS CUI [1,3])
C0036588 (UMLS CUI [1,4])
C0231171 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
C1533685 (UMLS CUI [2,3])
C0036588 (UMLS CUI [2,4])
Pregnancy | Breast Feeding
Item
pregnancy and breast-feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Heart Disease Serious | Heart Disease | Cardiac Arrhythmia Uncontrolled | Angina Pectoris Uncontrolled | Cardiomyopathy | Congestive heart failure Uncontrolled
Item
serious or acute heart disease such as uncontrolled cardiac dysrhythmias, uncontrolled angina pectoris, cardiomyopathy, or uncontrolled congestive heart failure, as per investigator opinion
boolean
C0018799 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0018799 (UMLS CUI [2])
C0003811 (UMLS CUI [3,1])
C0205318 (UMLS CUI [3,2])
C0002962 (UMLS CUI [4,1])
C0205318 (UMLS CUI [4,2])
C0878544 (UMLS CUI [5])
C0018802 (UMLS CUI [6,1])
C0205318 (UMLS CUI [6,2])
Substance Use Disorders
Item
current or past (within the last 2 years) history of alcohol or drug abuse
boolean
C0038586 (UMLS CUI [1])
Medical contraindication Interferon beta-1a
Item
have any contra-indications to treatment with interferon beta-1a according to summary of product characteristics
boolean
C1301624 (UMLS CUI [1,1])
C0254119 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial